別品名 |
Idamycin, Zavedos, (7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-α-L- lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11- trihydroxy-5,12-naphthacenedione hydrochloride
|
別包装 |
あり
|
純度 |
>=98%
|
分子量 |
533.96
|
CAS RN® |
57852-57-0
|
化合物の概要 |
Anthracycline, DNA intercalator; topoisomerase II inhibitor.
|
構造 |
C26H27NO9 HCl
|
溶媒 |
Soluble in water and methanol.
|
使用目的 |
Idarubicin is an anthracycline and daunorubicin analog that exhibits anticancer chemotherapeutic activity; it is clinically used to treat leukemias. Idarubicin intercalates DNA, inhibiting topoisomerase II and inducing double-stranded DNA breaks and causing histone eviction.
|
その他 |
[融点]183℃-185℃ [外観]Orange-red powder; odorless
|
参考文献 |
Eda Satana Kara H. Redox mechanism of anticancer drug idarubicin and in-situ evaluation of interaction with DNA using an electrochemical biosensor. Bioelectrochemistry. 2014 Oct;99:17-23. PMID: 24967755.Pang B, Qiao X, Janssen L, et al. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun. 2013;4:1908. PMID: 23715267.Crivellari D, Lombardi D, Spazzapan S, et al. New oral drugs in older patients: a review of idarubicin in elderly patients. Crit Rev Oncol Hematol. 2004 Feb;49(2):153-63. PMID: 15012975.
|
※サムネイル画像をクリックすると拡大画像が表示されます。
|
|
|
メーカー |
品番 |
包装 |
LKT
|
I1400
|
5 MG
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
1週間程度
|
保存温度 |
-20℃
|
|